Safety Of A Second Dose Of Tenecteplase In Selected Acute Ischemic Stroke Patients Not Responding To The First Dose
Clinical trial NCT06801054 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06801054
- Sponsor
- Memorial Hermann Health System
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-01
- Primary completion
- 2026-06-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.